Related Experiment Video
Updated: May 3, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
26.6K
Mild Autonomous Cortisol Secretion: Approach to Diagnosis, Evaluation, and Management.
Catherine D Zhang1, Hershel Raff2
1Division of Endocrinology and Molecular Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Summary
Mild autonomous cortisol secretion (MACS) is common in adrenal nodules and linked to health problems. Management of MACS should be personalized, considering adrenalectomy for specific patients.
Area of Science:
- Endocrinology
- Radiology
- Internal Medicine
Background:
- Adrenal nodules are frequently found due to advances in imaging technology.
- Mild autonomous cortisol secretion (MACS) affects 20-50% of patients with adrenal nodules.
- MACS is linked to significant health issues, including heart disease, bone fractures, and increased mortality.
Purpose of the Study:
- To review the prevalence and clinical implications of MACS in patients with adrenal nodules.
- To discuss the association between MACS and multisystem morbidity.
- To highlight the importance of individualized management strategies for MACS.
Main Methods:
- Literature review of studies on adrenal nodules and MACS.
- Analysis of clinical data linking MACS to comorbidities.
- Evaluation of treatment outcomes for adrenalectomy in MACS patients.
Main Results:
- MACS is the most common hormonal abnormality in adrenal nodules.
- Patients with MACS have a higher risk of cardiometabolic disease, vertebral fractures, and mortality.
- Adrenalectomy may offer benefits for certain comorbidities in MACS patients.
Conclusions:
- MACS is a significant clinical finding in patients with adrenal nodules.
- The multisystem effects of MACS necessitate careful monitoring and management.
- Individualized treatment plans, potentially including surgery, are crucial for managing MACS.
Keywords:
Adrenal incidentalomaAdrenal noduleMild autonomous cortisol excessMild autonomous cortisol secretionMore Related Videos
Related Concept Videos
01:26Cushing Syndrome I: Introduction
36
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
36
01:19Cushing Syndrome II: Pathophysiology
24
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
24
01:27Adrenal Gland Disorders
3.7K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.7K
01:37Hypothalamic-Pituitary Axis
49.2K
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
49.2K
01:29Chronic Pancreatitis II: Collaborative Care
563
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
563
01:15Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K